Pricing
Medication + coaching + care.
Membership included free.
Compounded medications are produced in state-licensed compounding facilities and are not FDA-approved. Your provider determines the right medication for you. See Medication Safety Information. *Based on FDA-approved tirzepatide; patients still on treatment at 12 months. Individual results vary; results for compounded medications have not been established.
The trademarks, service marks, trade names, and products referenced on this site (including Ozempic® and Zepbound™) are the property of their respective owners. VivioMD is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly. Personalized compounded medications available through the VivioMD program are not manufactured by, or under the direction or control of, Novo Nordisk or Eli Lilly. Only Novo Nordisk has FDA-approved products containing semaglutide, under the trade name Ozempic®. Novo Nordisk does not sell semaglutide to any entities for use in compounding. Ozempic® is not FDA-approved for weight loss. Only Eli Lilly has FDA-approved products containing tirzepatide, under the trade name Zepbound™. Eli Lilly does not sell tirzepatide to any entities for use in compounding.
Pricing
Medication + coaching + care.
Membership included free.
Compounded medications are produced in state-licensed compounding facilities and are not FDA-approved. Your provider determines the right medication for you. See Medication Safety Information.
The trademarks, service marks, trade names, and products referenced on this site (including Ozempic® and Zepbound™) are the property of their respective owners. VivioMD is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly. Personalized compounded medications available through the VivioMD program are not manufactured by, or under the direction or control of, Novo Nordisk or Eli Lilly. Only Novo Nordisk has FDA-approved products containing semaglutide, under the trade name Ozempic®. Novo Nordisk does not sell semaglutide to any entities for use in compounding. Ozempic® is not FDA-approved for weight loss. Only Eli Lilly has FDA-approved products containing tirzepatide, under the trade name Zepbound™. Eli Lilly does not sell tirzepatide to any entities for use in compounding.
A 3-minute questionnaire. We ask about health history, goals, and what's worked (and hasn't) before.
A US-licensed physician reads your file and writes back with a plan — usually same-day, always within 24h.
Medication ships discreetly in 2 days. Message your clinician anytime. Adjust or cancel whenever.
Your body already makes GLP-1 to signal when you've had enough. The medication turns that signal up — cravings quiet down, the "food noise" fades, and eating less stops feeling like a fight.
Every diet you white-knuckled was a fight against your own biology — and biology usually wins. GLP-1 works with your body, not against it: provider-prescribed for weight management, in a plan built around you.
The FDA-approved versions — Wegovy® and Zepbound® — are among the most-studied weight treatments there are. In real-world data on tirzepatide, up to ~95% of year-long adherent patients lost 10%+ of body weight.*






*FDA-approved tirzepatide; patients adherent at 12 months. Individual results vary; results for compounded medications have not been established.
Still unclear? Message us — you'll talk to a real person within the hour.
Ask a clinician →Clinical services and medical treatments provided by US-licensed clinicians from our affiliated professional entities which are independent medical groups with a network of United States based health care providers. The medical groups determine eligibility based on medical history. To learn more click here.
In certain situations, where clinically appropriate, a provider may prescribe compounded medication, which is prepared by an independent state-licensed sterile compounding pharmacy partner. VivioMD is not a pharmacy or a manufacturer of any medication. Although compounded drugs are permitted to be prescribed under federal law, they are not FDA-approved as safe or effective and do not undergo FDA review for safety, effectiveness, or manufacturing quality.
The trademarks, service marks, trade names, and products referenced on this site (including Wegovy®, Ozempic®, Mounjaro®, and Zepbound™) are the property of their respective owners. VivioMD is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly. Personalized compounded medications available through the VivioMD program are not manufactured by, or under the direction or control of, Novo Nordisk or Eli Lilly. Only Novo Nordisk has FDA-approved products containing semaglutide, under the trade names Wegovy® and Ozempic®. Novo Nordisk does not sell semaglutide to any entities for use in compounding. Ozempic® is not FDA-approved for weight loss. Only Eli Lilly has FDA-approved products containing tirzepatide, under the trade names Mounjaro® and Zepbound™. Eli Lilly does not sell tirzepatide to any entities for use in compounding. Mounjaro® is not FDA-approved for weight loss.
Before and after photos are for illustration only. Testimonials may be paid for to patients/creators, and photos may be AI edited or paid for to patients/creators.